# US 2021/0276957 A1 · Nadph oxidase inhibitors, pharmaceutical composition comprising the same, and application thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0276957 A1
- Document ID: US20210276957A1
- Status: Published application
- Kind: A1
- Application number: 17/254,565
- Filed: 2019-06-20
- Published: 2021-09-09
- Earliest claimed: 2018-06-21
- Assignees: Taiwanj Pharmaceuticals Co., Ltd.
- Applicants: Taiwanj Pharmaceuticals Co., Ltd.
- Inventors: Syaulan S. YANG; Kuang Yuan LEE; Meng Hsien LIU; Yan-Feng JIANG; Yu-Shiou FAN; Chiung Wen WANG; Mei-Chi HSU
- Web page: https://patentgrep.com/patent/US20210276957A1

## CPC

- C07D 215/22: attached in position 2 or 4
- C07D 223/16: Benzazepines; Hydrogenated benzazepines
- C07D 215/26: Alcohols; Ethers thereof
- C07D 215/38: Nitrogen atoms (nitro radicals C07D215/18)
- C07D 401/10: linked by a carbon chain containing aromatic rings
- C07D 409/04: directly linked by a ring-member-to-ring-member bond
- C07D 491/056: with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
- C07D 495/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present disclosure relates to a compound of Formula I, or a geometric isomer, enantiomer, diastereomer, racemate, atropisomer, pharmaceutically acceptable salt, prodrug or solvate thereof. The present disclosure further relates to a composition comprising the compound of Formula (I). The compound and the composition described herein can be used to inhibit NADPH oxidase activity.

## Claims

### Claim 1

A compound of Formula I, or a geometric isomer, enantiomer, diastereomer, racemate, atropisomer, pharmaceutically acceptable salt, prodrug or solvate thereof:
Wherein
A is C6-C20 aryl optionally fused with C1-C20 heterocyclyl, or C1-C20 heteroaryl optionally fused with C1-C20 heterocyclyl, and A is optionally substituted with one or more C1-C10 alkyl, C6-C20 aryl, halogen, OR11, C(O)R11, C(O)OR11, NR11R12, SO2R11, or SO2(OR11);
B is C1-C10 alkyl, C6-C20 aryl, C1-C20 heteroaryl or C1-C20 heterocyclyl, and B is optionally substituted with one or more C1-C10 alkyl, C6-C20 aryl, C1-C20 heterocyclyl, halogen, OR21, C(O)R21, C(O)OR21, NR21R22, SO2R21, or SO2(OR21), wherein said C1-C10 alkyl is optionally substituted with one or more halogen;
R11, R12, R21 and R22 independently are H, O, C1-C10 alkyl, or C6-C20 aryl, wherein said C1-C10 alkyl is optionally substituted with one or more halogen;
is a single bond or double bond;
n is 0 or 1;
X is N or C;
Y is H, OH or NH2;
Z is nil or C(O);
R3 and R4 independently are nil, H, C1-C10 alkyl or C6-C20 aryl; and
R5 is nil, H or C1-C10 alkyl.

### Claim 2 (depends on 1)

The compound of claim 1 represented by Formula II,
wherein
A is C6-C20 aryl optionally fused with C1-C20 heterocyclyl, or C1-C20 heteroaryl optionally fused with C1-C20 heterocyclyl, and A is optionally substituted with one or more C1-C10 alkyl, C6-C20 aryl, halogen, OR11, C(O)R11, C(O)OR11, NR11R12, SO2R11, or SO2(OR11);
B is C1-C10 alkyl, C6-C20 aryl, C1-C20 heteroaryl or C1-C20 heterocyclyl and is optionally substituted with one or more C1-C10 alkyl, C6-C20 aryl, C1-C20 heterocyclyl, halogen, OR21, C(O)R21, C(O)OR21, NR21R22, SO2R21, or SO2(OR21), wherein said C1-C10 alkyl is optionally substituted with one or more halogen;
R11, R12, R21 and R22 independently are H, O, C1-C10 alkyl, or C6-C20 aryl, wherein said C1-C10 alkyl is optionally substituted with one or more halogen;
Y is OH or NH2;
Z is nil or C(O); and
R5 is nil, H, or C1-C10 alkyl.

### Claim 3 (depends on 1)

The compound of claim 1 represented by Formula III,
Wherein
A is C6-C20 aryl optionally fused with C1-C20 heterocyclyl, or C1-C20 heteroaryl optionally fused with C1-C20 heterocyclyl, and A is optionally substituted with one or more C1-C10 alkyl, C6-C20 aryl, halogen, OR11, C(O)R11, C(O)OR11, NR11R12, SO2R11, or SO2(OR11);
B is C1-C10 alkyl, C6-C20 aryl, C1-C20 heteroaryl or C1-C20 heterocyclyl, and B is optionally substituted with one or more C1-C10 alkyl, C6-C20 aryl, C1-C20 heterocyclyl, halogen, OR21, C(O)R21, C(O)OR21, NR21R22, SO2R21, or SO2(OR21), wherein said C1-C10 alkyl is optionally substituted with one or more halogen;
R11, R12, R21 and R22 independently are H, O, C1-C10 alkyl, or C6-C20 aryl, wherein said C1-C10 alkyl is optionally substituted with one or more halogen;
Z is nil or C(O); and
each R3 and R4 independently is nil, H, C1-C10 alkyl or C6-C20 aryl.

### Claim 4 (depends on 1)

The compound of claim 1, wherein A is substituted or unsubstituted C6-C20 aryl or C6-C20 aryl fused with C1-C20 heterocyclyl.

### Claim 5 (depends on 4)

The compound of claim 4, wherein A is phenyl group substituted with one or more methoxy group, (dimethylamide) phenyl group, Br, OR11, or C(O)OR11, wherein Ru is H, O, C1-C10 alkyl, or C6-C20 aryl, wherein said C1-C10 alkyl is optionally substituted with one or more halogen.

### Claim 6 (depends on 1)

The compound of claim 1, wherein A is substituted or unsubstituted C1-C20 heteroaryl having at least one heteroatom selected from S, N, and O.

### Claim 7 (depends on 1)

The compound of claim 1, wherein A is substituted or unsubstituted C6-C20 aryl fused with C1-C20 heterocyclyl having at least one heteroatom selected from S, N, and O.

### Claim 8 (depends on 1)

The compound of claim 1, wherein B is substituted or unsubstituted C1-C10 alkyl.

### Claim 9 (depends on 1)

The compound of claim 1, wherein B is substituted or unsubstituted C6-C20 aryl.

### Claim 10 (depends on 12)

The compound of claim 12, wherein the B is a phenyl group substituted with one or more methyl, CF3, halogen, pyrrolidine, OR21, C(O)R21, NR21R22, or SO2R21.

### Claim 11 (depends on 13)

The compound of claim 13, wherein R21 is H, O, methyl, ethyl, n-propyl, or CF3; and R22 is H or O.

### Claim 12 (depends on 1)

The compound of claim 1, wherein B is substituted or unsubstituted C1-C20 heteroaryl.

### Claim 13 (depends on 1)

The compound of claim 1, wherein n is 0.

### Claim 14 (depends on 1)

The compound of claim 1, wherein X is C.

### Claim 15 (depends on 18)

The compound of claim 18, wherein Y is OH or NH2.

### Claim 16 (depends on 1)

The compound of claim 1, wherein Z is nil.

### Claim 17 (depends on 1)

The compound of claim 1, wherein R5 is nil, H or methyl.

### Claim 18 (depends on 1)

The compound of claim 1, wherein the compound is selected from a group consisting of:

### Claim 19 (depends on 1)

A pharmaceutical composition comprising a compound of claim 1 and at least a pharmaceutically acceptable excipient or carrier.

### Claim 20 (depends on 1)

A method of inhibiting NADPH oxidase (NOX), comprising:
administering to a cell an effective amount of the compound as recited in claim 1.
